|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000184012 |
Summary for TMPRSS2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000184012 | Gene symbol | TMPRSS2 |
| Gene name | transmembrane serine protease 2 | |
| HGNC | 11876 | |
| Entrez ID | 7113 | |
| Gene type | protein_coding | |
| Synonyms | TMPRSS2|PRSS10 | |
| UniProtAcc | O15393 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000184012 | TMPRSS2 | DB09019 | Bromhexine | SmallMoleculeDrug |
| ENSG00000184012 | TMPRSS2 | DB13729 | Camostat | SmallMoleculeDrug |
| ENSG00000184012 | TMPRSS2 | DB16737 | MM3122 | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for TMPRSS2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TMPRSS2 | 2.04e+02 | 1.37e+00 | 2.13e-01 | 6.43e+00 | 1.24e-10 | 9.02e-09 | KIRC |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TMPRSS2 | 5.17e+03 | -1.00e+00 | 2.68e-01 | -3.75e+00 | 1.77e-04 | 4.35e-04 | LUAD |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TMPRSS2 | 1.26e+03 | -1.12e+00 | 1.53e-01 | -7.34e+00 | 2.18e-13 | 5.53e-13 | BRCA |
| TMPRSS2 | 7.87e+03 | -1.26e+00 | 3.13e-01 | -4.04e+00 | 5.35e-05 | 2.79e-04 | READ |
Top |
Sex-biased somatic mutation for TMPRSS2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for TMPRSS2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for TMPRSS2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for TMPRSS2 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | TMPRSS2-009 | chr21_41485555_- | 5.41e-01 | 3.61e-01 | 2.65e+00 | 8.11e-03 | 2.68e-02 | 1.80e-01 |
| STAD | TMPRSS2-009 | chr21_41480856_- | 2.21e-01 | 3.17e-01 | -2.54e+00 | 1.12e-02 | 4.96e-02 | -9.56e-02 |
| ESCA | TMPRSS2-002 | chr21_41491271_- | 2.58e-01 | 1.60e-01 | 2.25e+00 | 2.47e-02 | 4.99e-02 | 9.83e-02 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | TMPRSS2-009 | chr21_41483422_- | 6.89e-01 | 3.86e-01 | 3.21e+00 | 1.31e-03 | 9.65e-03 | 3.02e-01 |
| ESCA | TMPRSS2-009 | chr21_41483422_- | 5.82e-01 | 3.72e-01 | 2.59e+00 | 9.53e-03 | 2.02e-02 | 2.10e-01 |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for TMPRSS2 |
TFs related to TMPRSS2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
TMPRSS2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for TMPRSS2 |
RBPs related to ES in TMPRSS2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KICH | G3BP2 | exon_skip_362119 | 8.87e+00 | 1.60e-02 | 9.15e+00 | 9.80e-01 | Female-biased |
| KICH | RBM6 | exon_skip_362112 | 9.45e+00 | 2.72e-03 | 9.89e+00 | 9.95e-01 | Female-biased |
TMPRSS2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs80325791 | chr21:36643093:A:T | - | 0.173321211723074 | 0.0142715657105082 | HNSC | Female-baised eQTL |
| rs8131150 | chr21:39305389:C:G | - | -0.160576980389074 | 0.0270846149941808 | LUSC | Female-baised eQTL |
| rs2064053 | chr21:35553774:G:A | - | 0.0984703795935262 | 0.0090450437676638 | KIRC | Female-baised eQTL |
| rs2834975 | chr21:35556775:A:T | - | 0.0974676131262681 | 0.0107646423283743 | KIRC | Female-baised eQTL |
| rs1040364 | chr21:35557114:C:T | - | 0.0974676131262681 | 0.0107646423283743 | KIRC | Female-baised eQTL |
| rs2834960 | chr21:35544968:T:C | - | 0.0973684252505327 | 0.0116108488634406 | KIRC | Female-baised eQTL |
| rs2835013 | chr21:35573999:A:G | - | -0.111308353942268 | 0.0304494452871539 | KIRC | Female-baised eQTL |
| rs61611661 | chr21:35552445:C:G | - | 0.090377837277949 | 0.0365721781991744 | KIRC | Female-baised eQTL |
| rs2834973 | chr21:35555159:C:T | - | 0.0903757264868106 | 0.0365784370838424 | KIRC | Female-baised eQTL |
| rs62218686 | chr21:35552404:G:A | - | 0.0905028005200001 | 0.0366136959252407 | KIRC | Female-baised eQTL |
| rs932282 | chr21:35550700:C:T | - | 0.0903001979113502 | 0.0377709793182813 | KIRC | Female-baised eQTL |
| rs760065 | chr21:35602644:A:G | - | -0.0993439682117528 | 0.0387666848255803 | KIRC | Female-baised eQTL |
| rs2834969 | chr21:35553210:T:C | - | 0.0895300713783955 | 0.0398333972329859 | KIRC | Female-baised eQTL |
| rs2834971 | chr21:35553411:G:C | - | 0.0895300713783955 | 0.0398333972329859 | KIRC | Female-baised eQTL |
| rs2064055 | chr21:35553616:C:A | - | 0.0895300713783955 | 0.0398333972329859 | KIRC | Female-baised eQTL |
| rs2064054 | chr21:35553629:T:A | - | 0.0895300713783955 | 0.0398333972329859 | KIRC | Female-baised eQTL |
| rs2064052 | chr21:35553822:A:G | - | 0.0895300713783955 | 0.0398333972329859 | KIRC | Female-baised eQTL |
| rs34247205 | chr21:35551363:T:G | - | 0.0893625756687764 | 0.0422714452768658 | KIRC | Female-baised eQTL |
| rs1734522 | chr21:35645980:A:C | - | -0.087915124210946 | 0.042887696491046 | KIRC | Female-baised eQTL |
| rs2834959 | chr21:35544918:G:T | - | 0.0892249919023704 | 0.0430655957452059 | KIRC | Female-baised eQTL |
| rs8128571 | chr21:35547694:C:T | - | 0.0892249919023704 | 0.0430655957452059 | KIRC | Female-baised eQTL |
| rs8129943 | chr21:39435131:G:A | - | -0.05645402799137 | 0.00158506455015426 | LUAD | Female-baised eQTL |
| rs11088476 | chr21:39440632:A:C | - | -0.0548479661960516 | 0.00367012549015136 | LUAD | Female-baised eQTL |
| rs3787925 | chr21:39454379:G:A | - | -0.0477762746410348 | 0.0138736381870588 | LUAD | Female-baised eQTL |
| rs4818049 | chr21:39538537:G:A | - | 0.0485398825408883 | 0.0271316874331062 | LUAD | Female-baised eQTL |
| rs3827209 | chr21:39454137:A:G | - | -0.0440564537366289 | 0.0278716016062813 | LUAD | Female-baised eQTL |
| rs2277788 | chr21:39445776:C:G | - | -0.043471020705161 | 0.0298042041295578 | LUAD | Female-baised eQTL |
| rs9979083 | chr21:39447285:T:G | - | -0.043471020705161 | 0.0298042041295578 | LUAD | Female-baised eQTL |
| rs2410157 | chr21:39462923:A:G | - | -0.0418098855574445 | 0.0338784602442326 | LUAD | Female-baised eQTL |
| rs8130752 | chr21:39459996:A:G | - | -0.0417636036328744 | 0.0341656688714251 | LUAD | Female-baised eQTL |
| rs7277386 | chr21:39464570:A:G | - | -0.0418036511848545 | 0.0363819122953026 | LUAD | Female-baised eQTL |
| rs975479 | chr21:39458096:G:C | - | -0.0404092095704485 | 0.0416486413491935 | LUAD | Female-baised eQTL |
| rs116286270 | chr21:31516081:A:C | - | 0.135159975608233 | 0.00307613387223692 | COAD | Female-baised eQTL |
| rs111296358 | chr21:31518570:G:A | - | 0.135159975608233 | 0.00307613387223692 | COAD | Female-baised eQTL |
| rs6517494 | chr21:38958842:T:G | - | -0.0648067300173766 | 0.0245308144801612 | COAD | Female-baised eQTL |
| rs138622229 | chr21:31494059:C:A | - | 0.114232148611685 | 0.0248549125000086 | COAD | Female-baised eQTL |
| rs1022423 | chr21:38960610:A:T | - | -0.0628935509010219 | 0.0401695661676219 | COAD | Female-baised eQTL |
| rs9305656 | chr21:38957958:T:G | - | -0.0628885408320645 | 0.0459103276342203 | COAD | Female-baised eQTL |
| rs2836785 | chr21:38957999:C:T | - | -0.0632078201134317 | 0.0462841989061465 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs467967 | chr21:38876883:G:A | - | 0.131485984853475 | 0.000142137816746879 | KIRC | Male-baised eQTL |
| rs8132183 | chr21:44498670:G:A | - | 0.123496834743574 | 0.00362838789386314 | KIRC | Male-baised eQTL |
| rs73362988 | chr21:40512830:G:A | - | 0.119416502156515 | 0.0082810922347242 | KIRC | Male-baised eQTL |
| rs73364926 | chr21:40528688:G:A | - | 0.114928889043325 | 0.0120825337433193 | KIRC | Male-baised eQTL |
| rs111836099 | chr21:44741727:G:A | - | 0.0940135831339536 | 0.0177199035701654 | KIRC | Male-baised eQTL |
| rs186847 | chr21:44735588:C:T | - | 0.0875363984441176 | 0.0300026877693335 | KIRC | Male-baised eQTL |
| rs235296 | chr21:44739555:G:A | - | 0.0874888504212627 | 0.0301990799060826 | KIRC | Male-baised eQTL |
| rs405117 | chr21:44734846:G:A | - | 0.0852891561994438 | 0.0368501811079057 | KIRC | Male-baised eQTL |
| rs201195818 | chr21:44738283:T:G | - | 0.085183804001686 | 0.0373964344244533 | KIRC | Male-baised eQTL |
| rs2570976 | chr21:44749472:A:T | - | 0.0840703242421058 | 0.04629362881867 | KIRC | Male-baised eQTL |
| rs437719 | chr21:44749729:G:A | - | 0.0840703242421058 | 0.04629362881867 | KIRC | Male-baised eQTL |
| rs462574 | chr21:41464802:A:G | gene,exon,UTR | -0.157316153722598 | 0.00383797657596011 | LUAD | Male-baised eQTL |
| rs113439507 | chr21:33987007:C:T | - | 0.144658102123171 | 0.00920797005771022 | LUAD | Male-baised eQTL |
| rs111718325 | chr21:33987168:C:T | - | 0.144658102123171 | 0.00920797005771022 | LUAD | Male-baised eQTL |
| rs75585764 | chr21:33987891:C:G | - | 0.14458913184375 | 0.00933315119954359 | LUAD | Male-baised eQTL |
| rs117153933 | chr21:33985578:A:T | - | 0.144248390695463 | 0.00957690304280303 | LUAD | Male-baised eQTL |
| rs112426803 | chr21:33987125:G:A | - | 0.144248390695463 | 0.00957690304280303 | LUAD | Male-baised eQTL |
| rs74766371 | chr21:33988011:T:C | - | 0.144248485054043 | 0.00973743727255214 | LUAD | Male-baised eQTL |
| rs455281 | chr21:41467145:G:T | gene | -0.150037698516206 | 0.0139869326229492 | LUAD | Male-baised eQTL |
| rs112138599 | chr21:33982501:C:T | - | 0.134427521422065 | 0.0183102119299356 | LUAD | Male-baised eQTL |
| rs76608815 | chr21:33980963:C:T | - | 0.129856198207191 | 0.0258480003654538 | LUAD | Male-baised eQTL |
| rs111585689 | chr21:33874805:C:T | - | 0.13499882682171 | 0.038143587051994 | LUAD | Male-baised eQTL |
| rs12627323 | chr21:33960832:G:A | - | 0.122395432953725 | 0.0403929388253212 | LUAD | Male-baised eQTL |
| rs78178570 | chr21:33876879:A:G | - | 0.134083765703806 | 0.0415636727182309 | LUAD | Male-baised eQTL |
| rs75912728 | chr21:33949755:C:T | - | 0.120135669812597 | 0.0455072461073383 | LUAD | Male-baised eQTL |
| rs78180321 | chr21:33950012:G:A | - | 0.120135669812597 | 0.0455072461073383 | LUAD | Male-baised eQTL |
| rs139225221 | chr21:33950893:A:G | - | 0.120135669812597 | 0.0455072461073383 | LUAD | Male-baised eQTL |
| rs78258279 | chr21:33954962:A:G | - | 0.120135669812597 | 0.0455072461073383 | LUAD | Male-baised eQTL |
| rs16991110 | chr21:33974004:T:G | - | 0.120558891411139 | 0.047468540137115 | LUAD | Male-baised eQTL |
| rs2236645 | chr21:33969937:C:T | - | 0.119702792853568 | 0.0477946646741096 | LUAD | Male-baised eQTL |
| rs7279523 | chr21:40193383:G:A | - | 0.128411539045793 | 0.0384434311878318 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg01157146 | chr21:41505711 | gene | -0.485267248277739 | 1.81949421025035e-27 | -0.703450537298815 | 2.474624164815372e-31 | KIRP |
| cg26309194 | chr21:41508630 | gene | -0.0487887554093002 | 2.24897732897646e-05 | -0.31397153351590223 | 3.4179487682724806e-07 | LIHC |
| cg24901042 | chr21:41508627 | gene | -0.0481932537204343 | 2.48298700401975e-05 | -0.31393498542027465 | 3.429258315280522e-07 | LIHC |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of TMPRSS2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000184012 | TMPRSS2 | C0033578 | Prostatic Neoplasms | 4 | CTD_human |
| ENSG00000184012 | TMPRSS2 | C0376358 | Malignant neoplasm of prostate | 4 | CTD_human |